Adam B. Weiner

2.7k total citations · 1 hit paper
75 papers, 1.6k citations indexed

About

Adam B. Weiner is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Adam B. Weiner has authored 75 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 22 papers in Oncology. Recurrent topics in Adam B. Weiner's work include Prostate Cancer Diagnosis and Treatment (41 papers), Prostate Cancer Treatment and Research (40 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Adam B. Weiner is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (41 papers), Prostate Cancer Treatment and Research (40 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Adam B. Weiner collaborates with scholars based in United States, Canada and United Kingdom. Adam B. Weiner's co-authors include Edward M. Schaeffer, Scott E. Eggener, Richard S. Matulewicz, Etelvino José Henriques Bechara, Ruth Halaban, Camila Marinho Mano, Kazumasa Wakamatsu, Antonella Bacchiocchi, Douglas E. Brash and Sanjay Premi and has published in prestigious journals such as Science, JAMA and Nature Communications.

In The Last Decade

Adam B. Weiner

67 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure

2015 396 citations Adam B. Weiner et al. profile →

Peers

Countries citing papers authored by Adam B. Weiner

Since Specialization

Citations

This map shows the geographic impact of Adam B. Weiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam B. Weiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam B. Weiner more than expected).

Fields of papers citing papers by Adam B. Weiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam B. Weiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam B. Weiner. The network helps show where Adam B. Weiner may publish in the future.

Co-authorship network of co-authors of Adam B. Weiner

This figure shows the co-authorship network connecting the top 25 collaborators of Adam B. Weiner. A scholar is included among the top collaborators of Adam B. Weiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam B. Weiner. Adam B. Weiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Androgen receptor–regulated lncRNA PRCAT71 promotes AR signaling through the interaction with KHSRP in prostate cancer 2025 ·Science Advances ·Yongyong Yang, Ting-You Wang, (unknown), (unknown), Yanan Ren, Adam B. Weiner, (unknown), (unknown), (unknown), Rui Wang, (unknown), Yu Wan, Zhe Ji, Xuesen Dong, Tamara L. Lotan, Edward M. Schaeffer, Rendong Yang, Qi Cao	0
2	Identifying cribriform and intraductal histology on magnetic resonance imaging‐assisted biopsy for patients with intermediate‐grade prostate cancer: Implications for active surveillance 2025 ·Cancer ·(unknown), (unknown), (unknown), Timothy J. Daskivich, Steven S. Raman, Anthony Sisk, Wayne Brisbane, Robert E. Reiter, Adam B. Weiner	0
3	Genomic Biomarker for Prostate Cancer Focal Therapy: Post Hoc Assessment of a Phase II Clinical Trial 2025 ·JCO Precision Oncology ·Adam B. Weiner, (unknown), (unknown), (unknown), (unknown), (unknown), Elai Davicioni, Anthony Sisk, Wayne Brisbane, Leonard S. Marks	0
4	Clinical Responses to Prostate-specific Membrane Antigen Radioguided Salvage Lymphadenectomy for Prostate Cancer Recurrence: Results from a Prospective Exploratory Trial 2024 ·European Urology Open Science ·Adam B. Weiner, (unknown), Catherine Meyer, (unknown), (unknown), (unknown), (unknown), Giuseppe Carlucci, Robin Grant, Johannes Czernin, Jérémie Calais, Robert E. Reiter	2
5	Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review 2024 ·European Urology ·Adam B. Weiner, (unknown), Andrew J. Armstrong, Alberto Bossi, Philip Cornford, Felix Y. Feng, Pratik Kanabur, R. Jeffery Karnes, Rana R. McKay, Todd M. Morgan, Edward M. Schaeffer, Neal D. Shore, Alison Tree, Daniel E. Spratt	13
6	International Variations in Adherence to Quality Metrics for Locoregional Prostate Cancer 2024 ·European Urology Oncology ·Adam B. Weiner, (unknown), Amar U. Kishan, Robert E. Reiter, Mark S. Litwin	0
7	Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI 2024 ·Journal of Nuclear Medicine ·Ida Sonni, Adam B. Weiner, (unknown), M. S. Deol, David Ban, Hye Ok Kim, Tristan Grogan, Preeti Ahuja, Nashla Barroso, Yang Zong, (unknown), Anthony Sisk, Johannes Czernin, William Hsu, Jérémie Calais, Robert E. Reiter, Steven S. Raman	1
8	Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer 2022 ·Cancer ·Adrianna A. Mendes, Jiayun Lu, Harsimar Kaur, Siqun L. Zheng, Jianfeng Xu, Jessica Hicks, Adam B. Weiner, Edward M. Schaeffer, Ashley E. Ross, Steven P. Balk, Mary‐Ellen Taplin, Nathan A. Lack, (unknown), Janielle P. Maynard, Angelo M. De Marzo, Emmanuel S. Antonarakis, Karen S. Sfanos, Corinne E. Joshu, Eugene Shenderov, Tamara L. Lotan	18
9	High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments 2022 ·Prostate Cancer and Prostatic Diseases ·Adam B. Weiner, Christina Y. Yu, (unknown), Yang Liu, Elai Davicioni, Antonina Mitrofanova, Tamara L. Lotan, Edward M. Schaeffer	2
10	First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature 2022 ·European Urology Oncology ·Adam B. Weiner, Aisha L. Siebert, Sarah E. Fenton, Wassim Abida, Neeraj Agarwal, Ian D. Davis, Tanya B. Dorff, Martin Gleave, Nicholas D. James, Darren M.C. Poon, Hiroyoshi Suzuki, Christopher J. Sweeney	3
11	It's all in the name: Does nomenclature for indolent prostate cancer impact management and anxiety? 2021 ·Cancer ·(unknown), (unknown), (unknown), Adam B. Weiner, Amanda X. Vo, (unknown), Stephen Jan, Edward M. Schaeffer, Shilajit Kundu	7
12	A transcriptomic model for homologous recombination deficiency in prostate cancer 2021 ·Prostate Cancer and Prostatic Diseases ·Adam B. Weiner, Yang Liu, Matthew McFarlane, Pushpinder Bawa, Eric V. Li, (unknown), Ziwen Li, (unknown), (unknown), R. Jeffrey Karnes, Elai Davicioni, Zachery R. Reichert, Arul M. Chinnaiyan, Tamara L. Lotan, Daniel E. Spratt, Edward M. Schaeffer	10
13	Cause of death during prostate cancer survivorship: A contemporary, US population–based analysis 2021 ·Cancer ·Adam B. Weiner, Eric V. Li, (unknown), David J. Press, Edward M. Schaeffer	40
14	Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes 2021 ·Nature Communications ·Adam B. Weiner, Thiago Vidotto, Yang Liu, Adrianna A. Mendes, Daniela C. Salles, Farzana A. Faisal, Sanjana Murali, Matthew McFarlane, Eddie L. Imada, (unknown), Ziwen Li, Elai Davicioni, Luigi Marchionni, Arul M. Chinnaiyan, Stephen J. Freedland, Daniel E. Spratt, Jennifer D. Wu, Tamara L. Lotan, Edward M. Schaeffer	65
15	Changes in prostate‐specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men 2020 ·Cancer ·Adam B. Weiner, Amanda X. Vo, (unknown), Jim C. Hu, Daniel E. Spratt, Edward M. Schaeffer	10
16	Insurance coverage, stage at diagnosis, and time to treatment following dependent coverage and Medicaid expansion for men with testicular cancer 2020 ·PLoS ONE ·Adam B. Weiner, Stephen Jan, (unknown), (unknown), (unknown), Shilajit Kundu	10
17	Medicaid Expansion Did not Improve Time to Treatment for Young Patients With Metastatic Renal Cell Carcinoma 2020 ·Clinical Genitourinary Cancer ·(unknown), Minh N. Pham, Adam B. Weiner, Mohammad R. Siddiqui, (unknown), (unknown), (unknown), Amanda X. Vo, Shilajit Kundu	3
18	Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study 2020 ·Prostate Cancer and Prostatic Diseases ·Adam B. Weiner, (unknown), Eric V. Li, Amanda X. Vo, (unknown), (unknown), Robert B. Nadler, Alicia K. Morgans	6
19	National practice patterns for lymph node irradiation in 197,000 men receiving external beam radiotherapy for localized prostate cancer 2019 ·Urologic Oncology Seminars and Original Investigations ·Adam B. Weiner, (unknown), (unknown), Daniel E. Spratt, Jim C. Hu, Edward M. Schaeffer	3
20	Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study 2018 ·European Urology Oncology ·Adam B. Weiner, (unknown), Joshua J. Meeks	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact